FDA Approved: NICOTINE — Supplemental Application (P & L Development, LLC)

View source ↗

Summary

FDA approved a supplemental application for nicotine polacrilex (nicotine gum) submitted by P & L Development, LLC under ANDA 079038.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• NICOTINE POLACRILEX (nicotine polacrilex)

Snippet

SUPPL AP for NICOTINE (NICOTINE POLACRILEX)